Biocorrx (OTCMKTS:BICX) Posts Quarterly Earnings Results

Biocorrx (OTCMKTS:BICX) posted its quarterly earnings results on Tuesday. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.11, Zacks reports. The company had revenue of ($0.15) million during the quarter, compared to analyst estimates of $0.22 million.

Biocorrx Price Performance

BICX remained flat at $0.40 during midday trading on Wednesday. The company’s stock had a trading volume of 200 shares, compared to its average volume of 1,219. The company’s 50 day simple moving average is $0.35 and its 200-day simple moving average is $0.36. Biocorrx has a 12-month low of $0.20 and a 12-month high of $0.50. The firm has a market cap of $10.56 million, a PE ratio of -1.25 and a beta of 0.33.

Biocorrx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.